Cargando…

Targeting metastatic breast cancer with ANG1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (BBB)

We devoted this short interview piece with Dr Shou-Ching Tang at Augusta University to feature some promising results from a clinical phase II trial on a novel brain-penetrating peptide-paclitaxel-conjugate, ANG1005, in treating brain metastatic breast cancer. These results were presented by Dr. Tan...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fei, Tang, Shou-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136589/
https://www.ncbi.nlm.nih.gov/pubmed/30258901
http://dx.doi.org/10.1016/j.gendis.2017.01.004

Ejemplares similares